Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bidens pilosa is a medicinal plant commonly used in traditional Chinese medicine and other herbal systems. The name "复方鬼针草颗粒模拟剂" refers to a simulated (placebo) granule formulation used as a control in clinical trials for the compound preparation "复方鬼针草颗粒", which contains Bidens pilosa as one of its main ingredients. Bidens pilosa itself is known for its anti-inflammatory, antihypertensive, immunomodulatory, and antioxidant properties. Its mechanism of action involves multiple targets and pathways including modulation of vascular endothelial growth factor A (VEGFA), RAC-alpha serine/threonine-protein kinase (AKT1), interleukin-6 (IL-6), tumor necrosis factor (TNF), and related signaling pathways such as TNF signaling, HIF-1 signaling, cGMP-PKG pathway, PI3K-Akt pathway, and Toll-like receptor pathway. These actions contribute to effects on blood pressure regulation, inflammation reduction, cell proliferation inhibition, apoptosis modulation, and immune response[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bidens pilosa.